A detailed history of Acadian Asset Management LLC transactions in Cerus Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 517,697 shares of CERS stock, worth $859,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
517,697
Previous 15,707 3195.96%
Holding current value
$859,377
Previous $27,000 3229.63%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.7 - $2.39 $853,383 - $1.2 Million
501,990 Added 3195.96%
517,697 $899,000
Q2 2024

Aug 06, 2024

BUY
$1.62 - $2.04 $2,091 - $2,633
1,291 Added 8.96%
15,707 $27,000
Q1 2024

May 10, 2024

SELL
$1.66 - $2.42 $1,223 - $1,783
-737 Reduced 4.86%
14,416 $27,000
Q4 2023

Feb 13, 2024

BUY
$1.25 - $2.35 $18,941 - $35,609
15,153 New
15,153 $32,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $55,737 - $94,737
16,250 New
16,250 $57,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.